» Articles » PMID: 17078006

Efficacy of Probiotics and Nutrients in Functional Gastrointestinal Disorders: a Preliminary Clinical Trial

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2006 Nov 2
PMID 17078006
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to evaluate the efficacy and safety of commonly used probiotics and nutrients available for functional gastrointestinal disorders (FGID). Five different combinations of probiotics and nutrients, or placebo, were taken daily over 12 weeks. In this randomized controlled clinical trial, men and women 21 to 72 years of age with FGID symptoms of indigestion, bloating, and abdominal discomfort were assigned to one of six groups, 12 patients per group. Gastrointestinal Quality of Life Index (GIQLI) and visual analogue scale (VAS) for GI symptoms, SF-36, lactulose and mannitol test (LMT), and urine indican levels were evaluated. GIQLI, VAS scores, and LMT did not change significantly (P > 0.05). There were clinically notable improvements in two of the combination formulations. While the nonsignificant improvements in GI symptoms could suggest that combination probiotics and nutrients may be beneficial in conditions such as FGID, no conclusive evidence was found in this pilot trial. Further investigations to explore the findings are discussed.

Citing Articles

Probiotic MTCC 5856 as adjunct therapy in children's acute diarrhea-a randomized, double-blind, placebo-controlled study.

Majeed M, Nagabhushanam K, Arumugam S, Chadalavada N, Seepana J, Annamalai T Front Pediatr. 2024; 11:1338126.

PMID: 38269290 PMC: 10806110. DOI: 10.3389/fped.2023.1338126.


Washed microbiota transplantation improves symptoms and intestinal barrier function in patients with functional bowel disorders: a propensity-score matching analysis.

Ye X, Chen J, Wu L, Luo D, Ye X, Wu L BMC Gastroenterol. 2024; 24(1):45.

PMID: 38262980 PMC: 10804514. DOI: 10.1186/s12876-024-03131-z.


Probiotics in Functional Dyspepsia.

Tziatzios G, Gkolfakis P, Leite G, Mathur R, Damoraki G, Giamarellos-Bourboulis E Microorganisms. 2023; 11(2).

PMID: 36838317 PMC: 9964889. DOI: 10.3390/microorganisms11020351.


Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Xiao M, Zhong L, Lam W, Zhao Y, Gwee K, Holtmann G Trials. 2022; 23(1):454.

PMID: 35655286 PMC: 9161179. DOI: 10.1186/s13063-022-06396-5.


Efficacy of prebiotics and probiotics for functional dyspepsia: A systematic review and meta-analysis.

Zhang J, Wu H, Wang X, Xie J, Li X, Ma J Medicine (Baltimore). 2020; 99(7):e19107.

PMID: 32049821 PMC: 7035106. DOI: 10.1097/MD.0000000000019107.


References
1.
Laiho K, Ouwehand A, Salminen S, Isolauri E . Inventing probiotic functional foods for patients with allergic disease. Ann Allergy Asthma Immunol. 2002; 89(6 Suppl 1):75-82. DOI: 10.1016/s1081-1206(10)62128-x. View

2.
Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R . Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 2004; 93(2-3):97-108. DOI: 10.1016/j.imlet.2004.02.005. View

3.
Young R, Huffman S . Probiotic use in children. J Pediatr Health Care. 2003; 17(6):277-83. DOI: 10.1016/s0891-5245(03)00070-1. View

4.
Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A . Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Dig Dis Sci. 2002; 47(7):1530-7. DOI: 10.1023/a:1015815102175. View

5.
Hoa N, Baccigalupi L, Huxham A, Smertenko A, Van P, Ammendola S . Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol. 2000; 66(12):5241-7. PMC: 92451. DOI: 10.1128/AEM.66.12.5241-5247.2000. View